Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Postmarketing study evaluating the relationship between ORTHO EVRA and risks of venous thromboembolism, stroke, and myocardial infarction ha…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin [Phase 4]
This Phase 4 trial compared three-times-daily unfractionated heparin to twice-daily enoxaparin for venous thromboembolism prophylaxis after …
-
CLINICAL_TRIALS withdrawal · 2016-06-22Clinical Trial Update: Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
A multicenter registry study evaluating comparative effectiveness of venous thromboembolism management in trauma patients has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Study on the Clinical Course Of Pulmonary Embolism
A completed study evaluating the clinical course of pulmonary embolism. The snippet does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients [NA]
Completed clinical trial comparing bemiparin to enoxaparin for the prevention of venous thromboembolism in ICU patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-06-07Clinical Trial Update: Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose [Phase 3]
A Phase 3 clinical trial update evaluating pharmacogenetics-guided dosing to determine the maintenance dose of warfarin.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Incidence and Outcomes of Venous Thromboembolism
This clinical trial update summarizes the incidence and outcomes of venous thromboembolism in the studied population and notes that the tria…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
This update notes a completed clinical trial evaluating oral anticoagulant therapy for venous thrombosis as part of the SCOR in Thrombosis p…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism [Phase 3]
Phase 3 trial evaluating anticoagulation versus inferior vena cava filters in cancer patients with venous thromboembolism; the study was ter…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line [Phase 2]
Phase 2 study of AVE5026 for thrombosis prophylaxis in children with a central venous line was terminated.
-
FDA approval · 2016-04-25FDA Approved: SAVAYSA — Supplemental Application (Daiichi Sankyo Inc.)
The FDA approved a supplemental application for SAVAYSA (edoxaban tosylate) submitted by Daiichi Sankyo to modify the label, reflecting upda…
-
CLINICAL_TRIALS withdrawal · 2016-04-22Clinical Trial Update: Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
This study evaluating the Crux Vena Cava Filter System was withdrawn; no study results have been reported.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement [Phase 2]
Phase 2 trial assessing the efficacy and safety of TAK-442 for venous thromboembolism prevention in subjects undergoing total knee replaceme…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist [Phase 2]
Phase 2 trial results update on reinitiating anticoagulation after temporary withdrawal of a vitamin K antagonist in patients with atrial fi…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants [Phase 4]
Phase 4 clinical trial update assessing the prevalence and causes of preventable and serious adverse drug reactions from oral anticoagulants…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Prevention of Recurrent Venous Thromboembolism (PREVENT) [Phase 3]
A completed Phase 3 trial (PREVENT) sponsored by the National Heart, Lung, and Blood Institute evaluating prevention of recurrent venous thr…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Inflammation, Infection, and Future Cardiovascular Risk
This is a completed NHLBI clinical trial update examining how inflammation and infection relate to future cardiovascular risk. It discusses …
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture [NA]
A completed clinical trial investigating compression treatment for Achilles tendon rupture and its effects on complications and healing, wit…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty [Phase 2]
A Phase 2 clinical trial evaluating a prophylactic agent to prevent venous thromboembolism after total knee arthroplasty has completed.
-
FDA approval · 2016-02-18FDA Approved: FONDAPARINUX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for fondaparinux sodium from Dr. Reddy's Laboratories Limited, enabling a new generic version of the…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
A completed University of Washington clinical study examined the relationship between mutations, hormone therapy, and venous thromboembolism…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Eliquis Regulatory Post Marketing Surveillance (rPMS)
This update reports the completion of Eliquis (apixaban) regulatory post-marketing surveillance (rPMS). It concerns patients with venous thr…
-
EMA safety_alert · 2016-02-05EMA concludes defective device in ROCKET study does not impact Xarelto's safety
EMA states that a defective device in the ROCKET study does not impact the safety of Xarelto (rivaroxaban).
-
CLINICAL_TRIALS withdrawal · 2016-02-04Clinical Trial Update: Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)
The Bayer-sponsored trial evaluating rivaroxaban for venous thromboembolism prophylaxis after elective total knee replacement or total hip r…
-
CLINICAL_TRIALS research · 2016-01-22Clinical Trial Update: Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)
A clinical trial update describing patients with acute venous thromboembolism in the CPRD-HES dataset linked with Hospital Episode Statistic…